ImmunoPrecise Antibodies Ltd. (IPA)
NASDAQ: IPA · Real-Time Price · USD
0.493
-0.037 (-7.00%)
At close: Jan 21, 2025, 4:00 PM
0.606
+0.113 (22.98%)
Pre-market: Jan 22, 2025, 5:53 AM EST
ImmunoPrecise Antibodies Ratios and Metrics
Market cap in millions USD. Fiscal year is May - April.
Millions USD. Fiscal year is May - Apr.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Jan '25 Jan 21, 2025 | Apr '24 Apr 30, 2024 | Apr '23 Apr 30, 2023 | Apr '22 Apr 30, 2022 | Apr '21 Apr 30, 2021 | Apr '20 Apr 30, 2020 |
| Market Capitalization | 17 | 34 | 64 | 131 | 187 | 38 | |
| Market Cap Growth | -76.17% | -47.50% | -50.98% | -30.05% | 386.87% | -4.92% | |
| Enterprise Value | 26 | 40 | 61 | 107 | 178 | 40 | |
| Last Close Price | 0.49 | 1.28 | 2.57 | 5.56 | 9.76 | 2.77 | |
| PS Ratio | 0.77 | 1.89 | 4.21 | 8.66 | 12.87 | 3.80 | |
| PB Ratio | 0.64 | 1.36 | 1.51 | 2.23 | 4.05 | 3.54 | |
| P/TBV Ratio | 10.95 | 17.29 | 11.26 | 7.20 | 5.35 | - | |
| EV/Sales Ratio | 1.49 | 2.23 | 4.02 | 7.09 | 12.22 | 3.96 | |
| Debt / Equity Ratio | 0.50 | 0.40 | 0.13 | 0.04 | 0.06 | 0.30 | |
| Asset Turnover | 0.36 | 0.36 | 0.24 | 0.24 | 0.38 | 0.50 | |
| Inventory Turnover | 5.37 | 5.94 | 4.95 | 5.95 | 6.43 | 7.54 | |
| Quick Ratio | 0.71 | 0.98 | 2.14 | 3.59 | 7.56 | 0.80 | |
| Current Ratio | 1.01 | 1.41 | 2.84 | 4.03 | 8.05 | 0.97 | |
| Return on Equity (ROE) | -65.88% | -59.26% | -39.91% | -25.28% | -20.39% | -29.84% | |
| Return on Assets (ROA) | -13.68% | -12.78% | -18.33% | -13.04% | -8.83% | -9.18% | |
| Return on Capital (ROIC) | -16.75% | -15.63% | -21.96% | -15.12% | -10.40% | -12.61% | |
| Earnings Yield | -121.12% | -58.70% | -30.53% | -9.96% | -3.18% | -9.27% | |
| FCF Yield | -38.13% | -12.19% | -24.51% | -6.55% | -0.88% | -3.47% | |
| Buyback Yield / Dilution | -7.62% | -2.97% | -26.46% | -19.51% | -20.88% | -8.67% | |
| Total Shareholder Return | -7.62% | -2.97% | -26.46% | -19.51% | -20.88% | -8.67% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.